Rapid Reference to Anxiety

di Ballenger - Tylee • 2003 • dettagli prodotto

non più pubblicato

€ 15,59

Paga gli acquisti tra 30€ e 2.000€ in 3 rate
senza interessi. Scopri di più

DESCRIZIONE

Rapid Reference to Anxiety provides authoritative and accessible information for the primary care and hospital doctor to assist with treatment decisions. Topics covered include panic disorder, social anxiety disorder, generalized anxiety disorder, obsessive compulsive disorder and posttraumatic stress disorder.Each title in the Rapid Reference series covers diagnosis, prevention, treatment and management of the disease area. They also contain drug listings, clinical trial information, future developments, FAQs and website listings to keep the reader up to date with the disease area. With patients becoming better informed about the nature and management of their conditions, Rapid Reference is a timely new series that offers doctors easy access to the best information for patient care and management. ContentsIntroduction and background· Introduction to headache in primary care· Headaches commonly encountered in primary careMigraineTension-type headacheShort, sharp headachesCluster headacheSinus headache and other causes of facial painSecondary (sinister) headaches· Introduction to migraineMigraine sub-typesDefinition and epidemiology· The natural history (five phases) of a migraine attackProdrome, aura, headache, resolution, recoveryRisk factors and trigger factors· Epidemiology of migraineIncidence and prevalenceEffect of gender, race, income and other social and demographic factors· Burden of illness due to migraineBurden to the patient (symptomatology, disability, quality of life)Burden to society (direct and indirect costs of care)· AetiologyGenetic factorsNeurovascular hypothesisDiagnosis· IHS criteriaCriteria for use in primary care· Differential diagnosis of migraine from other headache disordersManagement of migraine· The current status of migraine management in primary careUnder-consultation, under-diagnosis and under-treatment· Management guidelines for migraineIntroduction to MIPCA, US Headache Consortium and US Primary Care Net guidelinesGeneral principles of managementPatient counselling and buy-inCareful diagnosisAssessment of migraine impactProduction of an individualized treatment plan Follow-upCurrent 'hot topics' of management· Is a diagnosis essential?· Early versus late treatment· Necessity for new guidelines· Management of chronic daily headacheMigraine treatment- IntroductionWhen to use acute and prophylactic medicationsUse of evidence-based medicine versus the 'real world' situation- Acute treatments for migraineAnalgesics and analgesic combinationsEfficacy and side effect profilesErgotamine and DHE Efficacy and side effect profilesTriptansMode of actionAvailable triptans and formulations- Efficacy and side effect profiles- Comparison of the triptans, based on available evidenceOther acute medications that are available in certain countries only (e.g. Stadol in USA)Recommendations for the choice of medication and how to use it- Prophylactic treatments for migraineBeta-blockers5-HT2 antagonistsTricyclic antidepressants and SSRIsSodium valproateOver-the-counter prophylactics (vitamin B2, magnesium, feverfew and aspirin)Other acute medications that are available in certain countries only (e.g. calcium antagonists)Recommendations for the choice of medication and how to use it- Non-pharmacological treatments for migraineBiofeedback and relaxationAcupuncture- omeopathy- Treatment for chronic daily headacheManagement of migraine in the primary care setting- Overall summary of the previous two sections- Role of the patient, pharmacist, nurse, GP and specialistFrequently asked questions - By the GP to the specialist- By the patient to the GPFuture developments in migraine managementReferencesAppendices- List of available drugs and contraindications, side effects, cost implications- Useful addresses and websites for the GP and the patientProfessional societies and journalsPatient support organizations and charities